Item 8.01 Other Events.
On June 26, 2022, Brookline Capital Acquisition Corp., a Delaware corporation
("BCAC"), entered into Amendment No. 1 (the "Amendment") to the Business
Combination Agreement dated as of March 17, 2022 among BCAC, Project Barolo
Merger Sub, Inc., a Delaware corporation, and Apexigen, Inc., a Delaware
corporation (the "Business Combination Agreement"), in order to increase the
number of directors of the BCAC Board and the board of directors of the
Surviving Corporation upon the Effective Time (such capitalized terms as defined
in the Business Combination Agreement) from seven to eight directors, and to
increase the number of directors selected by Apexigen from six to seven
directors. The Amendment is filed as Exhibit 2.1 hereto and incorporated by
reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit Description
2.1 Amendment No. 1 to Business Combination Agreement dated as of
June 26, 2022 among Brookline Capital Acquisition Corp., a Delaware
corporation, Project Barolo Merger Sub, Inc., a Delaware corporation,
and Apexigen, Inc., a Delaware corporation.
104 Cover page Interactive data file (embedded with in the inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses